Certara has partnered with Nvidia to enhance its AI platform by integrating the BioNeMo toolkit, which leverages Nvidia’s specialized AI capabilities for biological and pharmaceutical applications. The collaboration aims to strengthen Certara’s computational drug discovery and development offerings through advanced generative AI models designed for the life sciences sector.